sparfloxacin has been researched along with Burns in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boyce, ST; Holder, IA | 1 |
| Blatun, LA; Grishina, IA; Iakovlev, VP; Izotova, GN; Krutikov, MG | 1 |
1 trial(s) available for sparfloxacin and Burns
| Article | Year |
|---|---|
[Clinical and laboratory efficacy of the novel difluoroquinolone Sparflo (sparfloxacin) in therapy of skin and soft tissue infections].
Topics: Acinetobacter; Adolescent; Adult; Aged; Anti-Infective Agents; Burns; Female; Fluoroquinolones; Humans; Male; Middle Aged; Proteus mirabilis; Soft Tissue Infections; Staphylococcus; Surgical Wound Infection | 2000 |
1 other study(ies) available for sparfloxacin and Burns
| Article | Year |
|---|---|
Agar well diffusion assay testing of bacterial susceptibility to various antimicrobials in concentrations non-toxic for human cells in culture.
Topics: Anti-Infective Agents; Burns; Cells, Cultured; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Mupirocin; Polymyxin B; Pseudomonas aeruginosa; Quinolones | 1994 |